123 related articles for article (PubMed ID: 11387375)
21. Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer.
Cohen SJ; Leichman CG; Yeslow G; Beard M; Proefrock A; Roedig B; Damle B; Letrent SP; DeCillis AP; Meropol NJ
Clin Cancer Res; 2002 Jul; 8(7):2116-22. PubMed ID: 12114411
[TBL] [Abstract][Full Text] [Related]
22. Other fluorinated pyrimidines in the treatment of solid tumors.
Saad ED; Hoff PM
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):65-8. PubMed ID: 11219980
[TBL] [Abstract][Full Text] [Related]
23. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
Shirasaka T; Taguchi T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
[TBL] [Abstract][Full Text] [Related]
24. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract][Full Text] [Related]
25. Complete response of a gastric primary after a short but toxic course of 'S-1' EORTC Early Clinical Studies Group.
Schöffski P; Chollet P; Ganser A; Wiese KH; Rambusch E; de Vries MJ; Hanauske A
Ann Oncol; 1999 Sep; 10(9):1117-20. PubMed ID: 10572613
[TBL] [Abstract][Full Text] [Related]
26. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
[TBL] [Abstract][Full Text] [Related]
27. [S-1 for treatment of breast cancers].
Saeki T; Takashima S
Nihon Rinsho; 2000 Apr; 58 Suppl():284-91. PubMed ID: 11026008
[No Abstract] [Full Text] [Related]
28. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
Ajani JA
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985
[TBL] [Abstract][Full Text] [Related]
29. [A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function].
Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Tanaka J; Oshiro R; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Takemoto H; Kondo M; Kamigaki S; Kawasaki T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1748-51. PubMed ID: 16315929
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function.
Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
Cancer Chemother Pharmacol; 2002 Jul; 50(1):25-32. PubMed ID: 12111108
[TBL] [Abstract][Full Text] [Related]
31. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
32. Development of a pharmacokinetic model to optimize the dosage regimen of TS-1, a combination preparation of tegafur, gimeracil and oteracil potassium.
Inoue S; Ohtani H; Tsujimoto M; Hori S; Sawada Y
Drug Metab Pharmacokinet; 2007 Jun; 22(3):162-8. PubMed ID: 17603216
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 5-FU plasma concentration by 13C breath test in patients treated with oral 5-FU analogs.
Higashida M; Matsumoto H; Kubota H; Murakami H; Kawabe Y; Nakashima H; Oka Y; Okumura H; Nakamura M; Hirai T
Anticancer Res; 2012 Dec; 32(12):5407-14. PubMed ID: 23225444
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of 5-fluorouracil in elderly Japanese patients with cancer treated with S-1 (a combination of tegafur and dihydropyrimidine dehydrogenase inhibitor 5-chloro-2,4-dihydroxypyridine).
Fujita K; Nakayama H; Ichikawa W; Yamamoto W; Endo H; Nagashima F; Tanaka R; Miya T; Sunakawa Y; Yamashita K; Mizuno K; Ishida H; Araki K; Narabayashi M; Miwa K; Ando Y; Akiyama Y; Kawara K; Hirose T; Sasaki Y
Drug Metab Dispos; 2009 Jul; 37(7):1375-7. PubMed ID: 19389859
[TBL] [Abstract][Full Text] [Related]
35. Experimental study to evaluate the usefulness of S-1 in a model of peritoneal dissemination of gastric cancer.
Mori T; Fujiwara Y; Yano M; Tamura S; Yasuda T; Takiguchi S; Monden M
Gastric Cancer; 2003; 6 Suppl 1():13-8. PubMed ID: 12775014
[TBL] [Abstract][Full Text] [Related]
36. Effect of dimethylnitrosamine-induced liver dysfunction on the pharmacokinetics of 5-fluorouracil after administration of S-1, an antitumour drug, to rats.
Yoshisue K; Kanie S; Nishimura T; Chikamoto J; Nagayama S
J Pharm Pharmacol; 2009 Dec; 61(12):1643-51. PubMed ID: 19958587
[TBL] [Abstract][Full Text] [Related]
37. [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Hiramatsu K; Mizukami Y; Momiyama M; Suzuki M; Niimi K; Nagashima T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1163-6. PubMed ID: 16121921
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetics of S-1].
Hirata K; Horikoshi N; Tominaga K; Sohma K; Yamaguchi K; Okazaki M; Furuhata T; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Yamamitsu S; Shirasaka T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():27-35. PubMed ID: 16897969
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic study of S-1 in patients in whom inulin clearance was measured.
Ando Y; Kawada K; Inada M; Morita S; Mitsuma A; Yasuda Y; Hiramatsu M; Fujimoto Y; Fujita K
Oncology; 2012; 83(1):38-44. PubMed ID: 22722580
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetics of 5-FU after S-1 oral administration for adjuvant chemotherapy in gastric cancer patients].
Matsumoto H; Hirai T; Hirabayashi Y; Murakami H; Higashida M; Kawabe Y; Fuchimoto M; Fujikura H; Hato S; Urakami A; Yamashita K; Tsunoda T
Gan To Kagaku Ryoho; 2007 Jun; 34(6):869-73. PubMed ID: 17565248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
